367 related articles for article (PubMed ID: 22316121)
1. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
[TBL] [Abstract][Full Text] [Related]
2. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
3. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
Kaushansky N; Eisenstein M; Boura-Halfon S; Hansen BE; Nielsen CH; Milo R; Zeilig G; Lassmann H; Altmann DM; Ben-Nun A
J Biol Chem; 2015 Jun; 290(24):15260-78. PubMed ID: 25911099
[TBL] [Abstract][Full Text] [Related]
4. DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Kaushansky N; Ben-Nun A
Front Oncol; 2014; 4():280. PubMed ID: 25360418
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma.
Mangalam A; Luckey D; Basal E; Behrens M; Rodriguez M; David C
J Immunol; 2008 Jun; 180(11):7747-56. PubMed ID: 18490779
[TBL] [Abstract][Full Text] [Related]
6. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
Mangalam AK; Khare M; Krco C; Rodriguez M; David C
Eur J Immunol; 2004 Jan; 34(1):280-90. PubMed ID: 14971054
[TBL] [Abstract][Full Text] [Related]
7. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
Lincoln MR; Ramagopalan SV; Chao MJ; Herrera BM; Deluca GC; Orton SM; Dyment DA; Sadovnick AD; Ebers GC
Proc Natl Acad Sci U S A; 2009 May; 106(18):7542-7. PubMed ID: 19380721
[TBL] [Abstract][Full Text] [Related]
8. Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.
Luckey D; Bastakoty D; Mangalam AK
J Autoimmun; 2011 Sep; 37(2):122-8. PubMed ID: 21632210
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
11. Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.
Mangalam AK; Luo N; Luckey D; Papke L; Hubbard A; Wussow A; Smart M; Giri S; Rodriguez M; David C
J Immunol; 2014 Nov; 193(10):4859-70. PubMed ID: 25339670
[TBL] [Abstract][Full Text] [Related]
12. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
13. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
14. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
15. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
16. High-resolution HLA class II sequencing of Swedish multiple sclerosis patients.
Akel O; Zhao LP; Geraghty DE; Lind A
Int J Immunogenet; 2022 Oct; 49(5):333-339. PubMed ID: 35959717
[TBL] [Abstract][Full Text] [Related]
17. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
[TBL] [Abstract][Full Text] [Related]
18. Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
Kumar A; Melis P; Genna V; Cocco E; Marrosu MG; Pieroni E
Mol Biosyst; 2014 Aug; 10(8):2043-54. PubMed ID: 24853027
[TBL] [Abstract][Full Text] [Related]
19. Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.
Quandt JA; Huh J; Baig M; Yao K; Ito N; Bryant M; Kawamura K; Pinilla C; McFarland HF; Martin R; Ito K
J Immunol; 2012 Sep; 189(6):2897-908. PubMed ID: 22888134
[TBL] [Abstract][Full Text] [Related]
20. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
Kort JJ; Kawamura K; Fugger L; Weissert R; Forsthuber TG
J Neuroimmunol; 2006 Apr; 173(1-2):23-34. PubMed ID: 16386804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
